As mentioned, the COVID-19 vaccine development seemed to meet the fast/good/cheap criteria due to unprecedented global collaboration, funding, and existing research on coronaviruses and mRNA technology. The FDA allowed simultaneous trial phases and that sped up development. mRNA technology enabled…   Read more»